mesothelioma
Owkin, Stanford Medicine Collaborate on AI-Driven Lung Cancer, Mesothelioma Biomarker Discovery
The French bioinformatics firm will analyze molecular and other multimodal data in search of new cancer therapeutics.
The firm's assay, dubbed MesoFind, uses an immunomagnetic capture method to identify surface antigens on mesothelioma pleural cells in a patient's blood sample.
In the hunt for an antigen in solid tumors that CAR T cells can target, researchers demonstrate the safety and efficacy profile of two such agents in early studies.
MSI Tumor Analysis Implicates Lynch Syndrome in Several New Cancer Types
In a pan-cancer analysis, Lynch syndrome genes were mutated more often than anticipated in tumors with high or intermediate levels of microsatellite instability.
New Genetic Variant Discovered to Cause Peritoneal Mesothelioma
Researchers identified unique ALK rearrangements in patients that lack previously known indicators of mesothelioma.
Feb 29, 2016
Study IDs Recurrent Mesothelioma Tumor Alterations
Sep 4, 2014
Aug 13, 2014
Cancer MDx Firm Castle Biosciences Raises $11.8M
Apr 8, 2011
Dec 30, 2010
CDC Plans $5M for Mesothelioma Biobank
Feb 18, 2010
Apr 30, 2009
Apr 30, 2009
Apr 16, 2009
Mar 5, 2009